Results 1 to 10 of about 1,703 (105)

S-palmitoylation and depalmitoylation at the interface of animal virus-host interactions [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology
Reversible protein S-palmitoylation, mediated by protein acyl transferases (PATs) and depalmitoylases, is essential for regulating numerous biological processes, including subcellular localization, protein stability, enzymatic activity, and protein ...
Rui-Qin Xu   +12 more
doaj   +2 more sources

Depalmitoylation by Palmitoyl-Protein Thioesterase 1 in Neuronal Health and Degeneration

open access: yesFrontiers in Synaptic Neuroscience, 2019
Protein palmitoylation is the post-translational, reversible addition of a 16-carbon fatty acid, palmitate, to proteins. Protein palmitoylation has recently garnered much attention, as it robustly modifies the localization and function of canonical ...
Akira Yoshii, Kevin Koster
exaly   +3 more sources

ABHD17C‐Mediated S‐Depalmitoylation of BCL6B Enhances CD24 Transcription to Resist Macrophage Phagocytosis in Pancreatic Cancer [PDF]

open access: yesAdvanced Science
The phagocytic function of macrophages plays a crucial role in the innate immune response against tumors. Alpha/beta hydrolase domain‐containing protein 17C (ABHD17C) is a kind of depalmitoyltransferase and its roles in tumor immunology remain largely ...
Yalu Zhang   +9 more
doaj   +2 more sources

Palmitoylation of TBK1 enhances the type I interferon signaling and strengthens anti-malarial immunity in mice [PDF]

open access: yesNature Communications
Precise regulation of type I interferon signaling is crucial for effective immune defense against infectious diseases. However, the molecular mechanisms governing this pathway are not fully understood.
Zhongxin Han   +10 more
doaj   +2 more sources

PPT1 regulation of HSP90α depalmitoylation participates in the pathogenesis of hyperandrogenism

open access: yesIScience, 2023
Summary: Ovarian granulosa cells (GCs) in the follicle are the important mediator of steroidogenesis and foster oocyte maturation. Evidences suggested that the function of GCs could be regulated by S-palmitoylation.
Bing Yao, Jinzhao Ma, Tongmin Xue
exaly   +3 more sources

Restoration of Osimertinib sensitivity in lung cancer through BRD4 inhibitor-mediated depalmitoylation of mutant EGFR via APT1 [PDF]

open access: yesnpj Precision Oncology
Non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations initially responds to the third-generation EGFR-tyrosine kinase inhibitor (TKI) Osimertinib.
Wolong Zhou   +6 more
doaj   +2 more sources

Influence of palmitoylation in axonal transport mechanisms in neurodegenerative diseases [PDF]

open access: yesFrontiers in Cellular Neuroscience
Progressive functional loss and death of neurons are characteristics of neurodegenerative diseases such as Alzheimer’s disease (AD), Amyotrophic lateral sclerosis (ALS), and Parkinson’s disease (PD).
Praveen B. S., Priti Talwar
doaj   +2 more sources

Depalmitoylase ABHD16A negatively regulates the anti-hepatitis B virus activity of IFITM1 [PDF]

open access: yesMicrobiology Spectrum
Interferon-inducible transmembrane (IFITM) proteins have been widely reported as antiviral factors against various viral pathogens. However, the mechanisms of IFITM regulation on hepatitis B virus (HBV), which induces chronic infection resulting in ...
Xin Wen   +8 more
doaj   +2 more sources

The Roles of Protein S-Palmitoylation in Cancers: From Dynamic Modulation to Therapeutic Potential [PDF]

open access: yesCancer Communications
Protein S-palmitoylation is a highly conserved posttranslational lipid modification that occurs on cysteine residues and critically influences protein maturation, subcellular localization, trafficking, and stability. Owing to its unique reversibility and
Haonan Zheng   +7 more
doaj   +2 more sources

Inhibition of BRD4 sensitizes NSCLC cells to osimertinib by suppressing APT1 and promoting MST1 palmitoylation [PDF]

open access: yesCell Death Discovery
Osimertinib is widely used to treat non-small-cell lung cancer (NSCLC) carrying epidermal growth factor receptor (EGFR) mutations. However, osimertinib resistance inevitably develops in almost all patients.
Shaoqiang Wang   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy